Skip to main content
. 2020 Apr 7;12(4):896. doi: 10.3390/cancers12040896

Figure 1.

Figure 1

Percentage of diagnostic apheresis products with circulating tumor cells (CTCs) detected by Isolation by SizE of Tumor cells (ISET) or CellSearch. The proportion of patients with CTCs (defined as either expressing TTF1/p40 or EpCAM, while lacking CD45) (A), and the proportion of patients with CTCs expressing the epithelial cell adhesion molecule (EpCAM) (B) have been shown.